Edison Investment Research Revenue and Competitors

License our Company Data API

London, UK

Location

N/A

Total Funding

Industry

Estimated Revenue & Valuation

Edison Investment Research's estimated annual revenue is currently $15M per year.(i)
Edison Investment Research's estimated revenue per employee is $83,333

Employee Data

Edison Investment Research has 180 Employees.(i)

Edison Investment Research's People

Name	Title	Email/Phone
1 Fraser Thorne	Founder, CEO	Reveal Email/Phone
2 Katherine Thompson	Head TMT Research	Reveal Email/Phone
3 Phillippa Britton	Head research production	Reveal Email/Phone
4 Sukie Thomson	Head Marketing	Reveal Email/Phone
5 Laine Yonker	VP, Investor Relations	Reveal Email/Phone
6 Joseph Green	Managing Director	Reveal Email/Phone
7 Soo Romanoff	Managing Director Healthcare	Reveal Email/Phone
8 Luke Crowson	Director	Reveal Email/Phone
9 Andy Murphy	Director Content, Industrials	Reveal Email/Phone
10 James Magness	Director, Energy & Resources	Reveal Email/Phone

Edison Investment Research Competitors & AlternativesAdd Company

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Conning Corpora...	$113.2M	424	1%	N/A	N/A
#2 Sentieo	$19.7M	141	-25%	$55.5M	N/A

Add Company

Show More Companies

What Is Edison Investment Research?

keywords:N/A

N/A

Total Funding

180

Number of Employees

$15M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Edison Investment Research News

2022-04-17 - Research Report Highlights Rising Demand for Biological Crop Protection Products in Sustainable Agriculture

Edison Investment Research, the London-based investment research and ... the growing investment interest in environmentally friendly crop...

2022-03-30 - SenSen Networks initiated by Edison Investment Research with a valuation upside of 50%

... of A$0.18 from Edison Investment Research, implying an upside of 50% from the current share price of A$0.12. Edison sees SenSen building...

2022-03-22 - Edison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow

Edison Investment Research Limited 04-Apr-2022 / 07:00 GMT/BST. London, UK, 4 April 2022. S&U (SUS): Seeing recovery and adapting to grow.

2021-10-21 - EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX

TEL AVIV, Israel and BETHESDA, Md., Oct. 21, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that EDISON Group issued a Healthcare QuickView publication on the company prepared by An ...

2021-10-19 - CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021

TEL AVIV, Israel and BETHESDA, Md., Oct. 19, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that Company CEO, Eyal Barad, will present at the upcoming Edison Open Forum: Cannabinoid ...

Other Companies in London

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 ebankIT	$25.7M	180	8%	N/A
#2 The i Paper	$15M	180	10%	N/A
#3 ELVIS	$49.5M	180	7%	N/A
#4 Cisilion	$28.7M	180	1%	N/A
#5 tyntec	$64.4M	180	N/A	N/A